TP53 and hepatocellular carcinoma: While the cellular and molecular determinants of p53-mediated tumor immune surveillance in hepatocellular carcinoma are only beginning to be uncovered, given the pleiotropic nature of p53-controlled responses, it is clear that identifying the precise cellular or molecular mechanisms that are involved in other tumor types is needed.